Pancreatic cancer accelerated by stress, finds study

January 10, 2018, Columbia University Medical Center

A new study shows that stress accelerates the development of pancreatic cancer by triggering the release of "fight-or-flight" hormones. Beta-blockers—commonly used medications that inhibit these hormones—were found to increase survival in a mouse model of the disease.

An additional analysis of patients with advanced revealed that those who were taking selective beta-blockers, which are used to treat heart conditions, lived approximately two-thirds longer than those who were not taking the medications.

The study, conducted by Columbia University Medical Center (CUMC) researchers, was published online in the journal Cancer Cell.

Recent studies have shown that emotional and psychological play a role in the development of tumors in general. This effect is thought to occur through the sympathetic nervous system, which releases hormones that give the body a surge of energy so that it can respond to perceived dangers.

"Some biologists dismissed this idea because stress is hard to measure," said study leader Timothy C. Wang, MD, the Dorothy L. and Daniel H. Silberberg Professor of Medicine at CUMC. "Others wondered how stress could possibly be related to a biological process that involves DNA mutations and the growth of cancer cells within a particular organ, such as the pancreas."

Stress promotes development of precancerous growths in pancreas

The current study was designed to find the links between stress and early development of pancreatic cancer. The researchers studied mice that are genetically predisposed to developing abnormal growths in the pancreas. The mice were raised in stressful living conditions (confined to a small space); control mice were raised in normal housing. After 14 weeks, 38 percent of the stressed mice were found to have neoplastic pancreatic lesions, a precursor to pancreatic cancer. No such lesions were observed in the controls.

"We know that you need a DNA mutation to start on the path to cancer, but our findings suggest that stress is doing something to move things along," said Dr. Wang.

Stress works via pancreatic nerves

That "something" was the subject of a subsequent experiment. Studies of the mice revealed that stress increases levels of catecholamines—the fight-or-flight hormones—in the bloodstream. Within the pancreas, catecholamines drive production of molecules that stimulate nerve growth around tumors. Those new nerves, in turn, promote tumor development and make more catecholamines, perpetuating the cycle. "In other words, stress sets up what we call a feed-forward loop between nerves and cancer cells that promotes tumor development," says Dr. Wang.

Beta-blockers may improve survival in pancreatic cancer

In experiments with a different mouse model of pancreatic cancer, the CUMC team demonstrated that treating mice with chemotherapy and nonselective beta-blockers, which are used to treat a variety of conditions, lived significantly longer than mice treated with chemotherapy alone.

The researchers also looked at survival in 631 patients who had surgery to treat advanced pancreatic cancer between 2002 and 2013. Those who were taking nonselective beta-blockers after surgery had a median survival of 40 months, about two-thirds longer than patients taking selective beta-blockers or neither type of ..

"It would be premature to recommend the use of beta-blockers for these patients, until we conduct prospective clinical studies said Dr. Wang. "But beta-blockers could potentially become part of the overall treatment regimen for cancer."

Can stress reduction can help prevent or slow prostate cancer?

"A handful of studies, and a lot of anecdotal evidence, suggest that maintaining a positive outlook is good for your health and can help with recovery from almost any disease. Will a positive outlook change the prognosis of a patient with advanced prostate cancer? Probably not. But it certainly won't hurt, and it could be part of the overall approach to slowing the progression of to allow other types of therapy to kick in," said Dr. Wang.

Explore further: Beta blockers may boost immunotherapy, help melanoma patients live longer

More information: The study is titled, "Beta2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer."

Related Stories

Beta blockers may boost immunotherapy, help melanoma patients live longer

January 8, 2018
A common, inexpensive drug that is used to prevent heart attacks and lower blood pressure may also help melanoma patients live longer, according to researchers.

Chronic stress hormones may promote resistance to EGFR inhibitors in lung cancer patients

November 8, 2017
Elevated levels of chronic stress hormones, such as those produced by psychological distress, may promote resistance to drugs commonly used to treat lung cancer patients with EGFR mutations, according to new research from ...

Do pancreatic cysts become cancerous?

November 21, 2017
What is a pancreatic cyst?

Generic heart medication shown to prolong ovarian cancer patients' survival

August 24, 2015
In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers. Survival was shown to be greatest ...

Prostate cancer cells thrive on stress

January 25, 2013
Not surprisingly, a cancer diagnosis creates stress. And patients with prostate cancer show higher levels of anxiety compared to other cancer patients.

Blood pressure drugs don't protect against colorectal cancer

May 14, 2012
A new study has found that, contrary to current thinking, taking beta blockers that treat high blood pressure does not decrease a person's risk of developing colorectal cancer. Published early online in CANCER, a peer-reviewed ...

Recommended for you

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

October 12, 2018
A new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.